SCHEMBL248105

SCHEMBL248105

On1cnnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28943824 0.78
SCHEMBL660325 0.60
SCHEMBL28523954 0.60
SCHEMBL828913 0.58
SCHEMBL29290128 0.58
SCHEMBL2228169 0.58
Hydrochloric Acid SCHEMBL784622 0.58
SCHEMBL14385212 0.58
SCHEMBL171550 0.53
SCHEMBL32662715 0.36

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662222-A1 PROCESS FOR THE PREPARATION OF TETRAPEPTIDE FRAGMENT OF LIRAGLUTIDE Fresenius Kabi Oncology Ltd (IN) 2025-12-17 EP claimed
EP-4646423-A1 PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED TRI-TERT-BUTYL-TRYPTOPHAN (TBT) RESIDUE Amicoat AS (NO) 2025-11-12 EP claimed
US-20250134812-A1 SYNTHETIC GLYCOLIPIDS AND GLYCOLIPOSOME COMPOSITIONS : SUITABLE FOR CARGO DELIVERY TO THE CENTRAL NERVOUS SYSTEM KORANEX CAPITAL (CA) 2025-05-01 US claimed
WO-2024166022-A1 PROCESS FOR THE PREPARATION OF TETRAPEPTIDE FRAGMENT OF LIRAGLUTIDE FRESENIUS KABI ONCOLOGY LTD (IN) 2024-08-15 WO claimed
WO-2024146948-A1 PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED TRI-TERT-BUTYL-TRYPTOPHAN (TBT) RESIDUE AMICOAT AS (NO) 2024-07-11 WO claimed
WO-2023141693-A1 SYNTHETIC GLYCOLIPIDS AND GLYCOLIPOSOME COMPOSITIONS SUITABLE FOR CARGO DELIVERY TO THE CENTRAL NERVOUS SYSTEM KORANEX CAPITAL (CA) 2023-08-03 WO claimed
WO-2023141692-A1 SYNTHETIC GLYCOLIPIDS AND GLYCOLIPOSOME COMPOSITIONS SUITABLE FOR CARGO DELIVERY TO THE CENTRAL NERVOUS SYSTEM KORANEX CAPITAL (CA) 2023-08-03 WO claimed
EP-2864403-A1 FOAMS CONTAINING BUTENE AND ETHYLENE NMC S.A. (BE) 2015-04-29 EP claimed
US-20140350301-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2014-11-27 US claimed
US-8658821-B2 Process for the preparation of nateglinide CIPLA LIMITED (IN) 2014-02-25 US claimed
US-20040082641-A1 Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases NOVO NORDISK A/S (DK) 2004-04-29 US claimed
US-20030186944-A1 Such as 4-(2-(3-dimethylaminobenzoylamino)phenoxy)phthalic acid for treatment/prevention of diabetes; for inhibiting liver glycogen phosphorylase; dietetics KRISTIANSEN MARIT (DK) 2003-10-02 US claimed
US-6590118-B1 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes) NOVO NORDISK A/S (DK) 2003-07-08 US claimed
JP-2003510304-A 2003-03-18 JP claimed
EP-1220832-A1 NOVEL AROMATIC COMPOUNDS NOVO NORDISK A/S (DK) 2002-07-10 EP claimed
WO-2001023347-A1 NOVEL AROMATIC COMPOUNDS NOVO NORDISK A/S (DK) 2001-04-05 WO claimed
WO-2000056721-A1 SOLID PHASE SYNTHESIS OF BENZODIAZEPINE DIONES AXYS PHARMACEUTICALS, INC. (US) 2000-09-28 WO claimed
US-6069257-A Process for the production of tetrazolylbenzopyrans SMITHKLINE BEECHAM P.L.C. (GB) 2000-05-30 US claimed
EP-0964861-A1 PROCESS FOR THE PRODUCTION OF TETRAZOLYLBENZOPYRANS SMITHKLINE BEECHAM PLC (GB) 1999-12-22 EP claimed
WO-1998030559-A1 PROCESS FOR THE PRODUCTION OF TETRAZOLYLBENZOPYRANS SMITHKLINE BEECHAM PLC (GB) 1998-07-16 WO claimed